www.aipessymposium.eu       www.aipes-eeig.org       2018 2015

Molecular Imaging

Guided Cancer Management

for European Citizens

An AIPES symposium

Thursday 22 March at 10:00 - The Solvay Library, Brussels

under the auspices

of MEP Aldo Patriciello

Novel cancer therapies are revolutionising patient management and offer improved outcomes, quality of life and hope for those affected by cancer and those around them. However, such therapies tend to be very expensive, and while effective for patients with specific genetic profiles of the disease, they have no effect on others with different genotypes.

This fact compromises their benefits versus mainstream approaches at population level, while imposing severe strains to health systems. Moreover, it increases the investment risk for the development of further novel treatment developments.


Molecular imaging is an accurate, safe and economic answer to these concerns. By utilising state-of-the-art technology, localisation of the disease and genetic suitability for a candidate therapy is possible. This enables individualised treatments, allowing health systems to offer the best possible solution to each citizen while simultaneously containing treatment costs.


• “Molecular Imaging today (PET & SPECT diagnosis & therapy)”

    Prof Andreas Buck, University Clinic of Würzburg, Germany

• “Benefits of Molecular Imaging in cancer management

    vs the cost of imaging”

    Dr. Johannes Czernin, M.D. Department of Nuclear Medicine, UCLA, USA

• “The Israeli experience. How PET/CT was accepted

    and reimbursed in the health system of Israel”

    Prof Einat Even-Sapir Weizer, MD, PhD., Head, The Institute

    of Nuclear Medicine, Tel Aviv Medical Center, Israel

• “The Future of Molecular Imaging / combining imaging with other

   diagnostics (e.g. liquid biopsies) for personalized medicine”

   Univ.-Prof. Dr. Marcus Hacker, M.D., Director, Division of Nuclear Medicine,  

   Medical University Vienna, Austria

• “The Role of industry in personalized medicine via Molecular Imaging”

    Dr James Williams, CEO at Siemens Healthineers Molecular Imaging,

    Knoxville, USA

• Panel discussion together with representatives from the EANM

• Networking-lunch


• Adam Smith D.Phil., Chief Scientific Officer, Nobel Media AB

  1. Antonis Kalemis PhD, Vice-President

Download the full program here

Click here for the photo gallery

Download the press release